摘要
目的比较冬眠灵和维思通治疗精神分裂症的临床效果。方法 123例精神分裂症患者被分为实验组和对照组,对照组给予冬眠灵治疗,实验组给予维思通治疗。结果实验组在GQOLI评分、PANSSE评分和副反应等方面均显著优于对照组。结论相比于冬眠灵,维思通具有更加显著的临床效果和更低的药物副反应,是值得考虑的临床药物之一。
Objective To compare the clinical effect of chlorpromazine and risperidone used for patients with schizophrenia. Methods 132 cases of patients with schizophrenia were divided into experimental group and control group, control group was given therapy of chlorpromazine and experimental group was given therapy of risperidone. Results The score of GQOLI, PANSSE and side-reactions in experimental group was significantly better than that in control group. Conclusion Compared with chlorpromazine, risperidone used for patients with schizophrenia showed better clinical effect and lower side-reaction, so it is one of the desirable drugs in clinical work.
出处
《当代医学》
2011年第8期141-142,共2页
Contemporary Medicine
关键词
冬眠灵
维思通
精神分裂症
Chlorpromazine
Risperidone
Schizophrenia
Life quality
